13F HOLDINGS REPORT
RTW INVESTMENTS, LP
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001493215-25-000003
Total Value
$6.54B
Positions
68
Other Managers
0
Confidential Omitted
No
Holdings (68)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MADRIGAL PHARMACEUTICALS INC | MDGL | 1,993,687 | $660.4M | 10.10% |
| 2 | ARGENX SE | ARGX | 673,497 | $398.6M | 6.10% |
| 3 | PTC THERAPEUTICS INC | PTCT | 7,483,127 | $381.3M | 5.83% |
| 4 | NATERA INC | NTRA | 2,593,546 | $366.8M | 5.61% |
| 5 | AXSOME THERAPEUTICS INC | AXSM | 2,922,729 | $340.9M | 5.21% |
| 6 | AKERO THERAPEUTICS INC | 00973Y108 | 7,419,340 | $300.3M | 4.59% |
| 7 | PROTAGONIST THERAPEUTICS INC | PTGX | 5,719,415 | $276.6M | 4.23% |
| 8 | AVIDITY BIOSCIENCES INC | 05370A108 | 8,746,926 | $258.2M | 3.95% |
| 9 | PENUMBRA INC | PEN | 862,770 | $230.7M | 3.53% |
| 10 | INSMED INC | INSM | 3,014,558 | $230.0M | 3.52% |
| 11 | ALKERMES PLC | ALKS | 6,884,698 | $227.3M | 3.48% |
| 12 | STRYKER CORPORATION | SYK | 590,221 | $219.7M | 3.36% |
| 13 | VERONA PHARMA PLC | 925050106 | 2,848,800 | $180.9M | 2.77% |
| 14 | MERUS N V | N5749R100 | 4,169,393 | $175.5M | 2.68% |
| 15 | TARSUS PHARMACEUTICALS INC | TARS | 3,316,032 | $170.3M | 2.61% |
| 16 | IMMUNOCORE HLDGS PLC | IMCR | 4,869,798 | $144.5M | 2.21% |
| 17 | ACADIA PHARMACEUTICALS INC | ACAD | 8,540,117 | $141.9M | 2.17% |
| 18 | ROCKET PHARMACEUTICALS INC | RCKTW | 17,687,772 | $118.0M | 1.80% |
| 19 | RADNET INC | RDNT | 2,317,582 | $115.2M | 1.76% |
| 20 | MASIMO CORP | MASI | 683,294 | $113.8M | 1.74% |
| 21 | ZAI LAB LTD | ZLAB | 3,136,680 | $113.4M | 1.73% |
| 22 | CYTOKINETICS INC | CYTK | 2,721,158 | $109.4M | 1.67% |
| 23 | ESTABLISHMENT LABS HLDGS INC | ESTA | 2,583,887 | $105.4M | 1.61% |
| 24 | APOGEE THERAPEUTICS INC | APGE | 2,712,097 | $101.3M | 1.55% |
| 25 | INTUITIVE SURGICAL INC | ISRG | 202,456 | $100.3M | 1.53% |
| 26 | GLOBUS MED INC | GMED | 1,125,000 | $82.3M | 1.26% |
| 27 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 1,707,402 | $61.8M | 0.95% |
| 28 | GH RESEARCH PLC | GHRS | 5,499,769 | $60.7M | 0.93% |
| 29 | SPYRE THERAPEUTICS INC | SYRE | 3,621,996 | $58.4M | 0.89% |
| 30 | UNIQURE NV | QURE | 4,265,428 | $45.2M | 0.69% |
| 31 | UROGEN PHARMA LTD | URGN | 3,834,794 | $42.4M | 0.65% |
| 32 | GE HEALTHCARE TECHNOLOGIES I | GEHC | 520,000 | $42.0M | 0.64% |
| 33 | CG ONCOLOGY INC | CGON | 1,701,216 | $41.7M | 0.64% |
| 34 | BETA BIONICS INC | BBNX | 3,299,870 | $40.4M | 0.62% |
| 35 | ORCHESTRA BIOMED HLDGS INC | OBIO | 8,206,162 | $35.1M | 0.54% |
| 36 | STOKE THERAPEUTICS INC | STOK | 5,123,525 | $34.1M | 0.52% |
| 37 | IMMATICS N.V | IMTX | 6,909,510 | $31.2M | 0.48% |
| 38 | TAYSHA GENE THERAPIES INC | TSHA | 18,787,866 | $26.1M | 0.40% |
| 39 | VERASTEM INC | VSTM | 4,245,476 | $25.6M | 0.39% |
| 40 | XENCOR INC | XNCR | 2,402,883 | $25.6M | 0.39% |
| 41 | ARVINAS INC | ARVN | 3,334,308 | $23.4M | 0.36% |
| 42 | LENZ THERAPEUTICS INC | LENZ | 863,389 | $22.2M | 0.34% |
| 43 | REPLIMUNE GROUP INC | REPL | 2,065,010 | $20.1M | 0.31% |
| 44 | ORUKA THERAPEUTICS INC | ORKA | 1,945,649 | $20.0M | 0.31% |
| 45 | TEMPUS AI INC | TEM | 400,000 | $19.3M | 0.30% |
| 46 | GLAUKOS CORP | GKOS | 190,000 | $18.7M | 0.29% |
| 47 | DYNE THERAPEUTICS INC | DYN | 1,690,567 | $17.7M | 0.27% |
| 48 | CARGO THERAPEUTICS INC | 14179K101 | 4,124,859 | $16.8M | 0.26% |
| 49 | QUEST DIAGNOSTICS INC | DGX | 98,997 | $16.8M | 0.26% |
| 50 | COMPASS PATHWAYS PLC | CMPS | 5,538,168 | $15.8M | 0.24% |
| 51 | NEUROGENE INC | NGNE | 1,348,656 | $15.8M | 0.24% |
| 52 | RAPT THERAPEUTICS INC | 75382E109 | 11,764,000 | $14.4M | 0.22% |
| 53 | 89BIO INC | 282559103 | 1,967,527 | $14.3M | 0.22% |
| 54 | CULLINAN THERAPEUTICS INC | CGEM | 1,705,960 | $12.9M | 0.20% |
| 55 | BEAM THERAPEUTICS INC | BEAM | 438,659 | $8.6M | 0.13% |
| 56 | CORVUS PHARMACEUTICALS INC | CRVS | 2,679,479 | $8.5M | 0.13% |
| 57 | PERCEPTIVE CAP SOLUTIONS COR | G70077105 | 742,500 | $7.6M | 0.12% |
| 58 | WAVE LIFE SCIENCES LTD | WVE | 900,000 | $7.3M | 0.11% |
| 59 | EXAGEN INC | XGN | 1,511,866 | $5.4M | 0.08% |
| 60 | KESTRA MED TECHNOLOGIES LTD | BEKE | 200,000 | $5.0M | 0.08% |
| 61 | ALLURION TECHNOLOGIES INC | ALURW | 1,050,063 | $3.4M | 0.05% |
| 62 | BIOAGE LABS INC | BIOA | 786,353 | $3.0M | 0.05% |
| 63 | CERIBELL INC | CBLL | 150,000 | $2.9M | 0.04% |
| 64 | TENAX THERAPEUTICS INC | TENX | 378,346 | $2.5M | 0.04% |
| 65 | MILESTONE PHARMACEUTICALS IN | MIST | 2,506,102 | $2.0M | 0.03% |
| 66 | CENTESSA PHARMACEUTICALS PLC | CNTA | 50,000 | $719,000 | 0.01% |
| 67 | ADAGIO MED HLDGS INC | 00534B100 | 209,361 | $168,515 | 0.00% |
| 68 | ROCKET PHARMACEUTICALS INC | RCKTW | 350,000 | $16,450 | 0.00% |